Association of bovine papillomavirus with the equine sarcoid

Journal of General Virology

Volumn 84, Issue 5, 2003, Pages 1055-1062

  Chambers, G ^a   Ellsmore, V A ^a   O'Brien, P M ^a   Reid, S W J ^a   Love, S ^a   Campo, M S ^a   Nasir, L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; ONCOPROTEIN; TRANSFORMING PROTEIN; VIRUS DNA; VIRUS RNA; VIRUS VACCINE;

CANCER SURGERY; CATTLE; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; HORSE; NONHUMAN; PAPILLOMA VIRUS; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REVIEW; SARCOIDOSIS; SKIN TUMOR; VIRION; VIRUS GENE; VIRUS INFECTION;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; HORSE DISEASES; HORSES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PARVOVIRUS; DNA VIRUSES; EQUIDAE; EQUUS CABALLUS; PAPILLOMAVIRUS; RNA VIRUSES;

EID: 0038664284     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18947-0     Document Type: Review

References (83)

1. Amtmann, E., Muller, H. & Sauer, G. (1980). Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol 35, 962-964.
2. Angelos, J. A., Oppenheim, Y., Rebhun, W., Mohammed, H. & Antczak, D. F. (1988). Evaluation of breed as a risk factor for sarcoid and uveitis in horses. Anim Genet 19, 417-425.
3. Angelos, J. A., Marti, E., Lazary, S. & Carmichael, L. E. (1991). Characterization of BPV-like DNA in equine sarcoids. Arch Virol 119, 95-109.
4. Ashrafi, G. H., Tsirimonaki, E., Marchetti, B., O'Brien, P. M., Sibbet, G. J., Andrew, L. & Campo, M. S. (2002). Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21, 248-259.
5. Bloch, N., Breen, M. & Spradbrow, P. B. (1994). Genomic sequences of bovine papillomaviruses in formalin-fixed sarcoids from Australian horses revealed by polymerase chain reaction. Vet Microbiol 41, 163-172.
6. Boiron, M., Levy, J. P., Thomas, M., Freidman, J. C. & Bernard, J. C. (1964). Some properties of bovine papillomavirus. Nature 201, 423.
7. Breitburd, F., Ramoz, N., Salmon, J. & Orth, G. (1996). HLA control in the progression of human papillomavirus infections. Semin Cancer Biol 7, 359-371.
8. Brostrom, H. (1989). Surface antigens on equine sarcoid cells and normal dermal fibroblasts as assessed by xenogenic antisera. Res Vet Sci 46, 172-179.
9. Brostrom, H. (1995). Equine sarcoids. A clinical and epidemiological study in relation to equine leucocyte antigens (ELA). Acta Vet Scand 36, 223-236.
10. Brostrom, H., Bredberg-Raden, U., England, J., Obel, N. & Perlmann, P. (1979). Cell-mediated immunity in horses with sarcoid tumours against sarcoid cells in vitro. Am J Vet Res 40, 1701-1706.
11. Brostrom, H., Fahlbrink, E., Dubath, M.-L. & Lazary, S. (1988). Association between equine leucocyte antigens (ELA) and equine sarcoid tumours in the population of Swedish halfbreds and some of their families. Vet Immunol Immunopathol 19, 215-223.
12. Bucher, K., Szalai, G., Marti, E., Griot-Wenk, M. E., Lazary, S. & Pauli, U. (1996). Tumour suppressor gene p53 in the horse: identification, cloning, sequencing and a possible role in the pathogenesis of equine sarcoid. Res Vet Sci 61, 114-119.
13. Campo, M. S. (1997a). Bovine papillomavirus and cancer. Vet J 154, 175-188.
14. Campo, M. S. (1997b). Vaccination against papillomavirus in cattle. Clin Dermatol 15, 275-283.
15. Campo, M. S., Grindlay, G. J., O'Neil, B. W., Chandrachud, L. M., McGarvie, G. M. & Jarrett, W. F. H. (1993). Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J Gen Virol 74, 945-953.
16. Carr, E. A., Theon, A. P., Madewell, B. R., Hitchcock, M. E., Schlegel, R. & Schiller, J. T. (2001a). Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am J Vet Res 62, 1212-1217.
17. Carr, E. A., Theon, A. P., Madewell, B. R., Griffey, S. M. & Hitchcock, M. E. (2001b). Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States. Am J Vet Res 62, 741-744.
18. Cheevers, W. P., Roberson, S. M., Brassfield, A. L., Davis, W. C. & Crawford, T. B. (1982). Isolation of a retrovirus from cultured equine sarcoid tumour cells. Am J Vet Res 43, 804-806.
19. Cheevers, W. P., Fatemi-Nainie, S. & Anderson, L. W. (1986). Spontaneous expression of an endogenous retrovirus by the equine sarcoid-derived MC-1 cell line. Am J Vet Res 47, 50-52.
20. Chen, J. J., Reid, C. E., Band, V. & Androphy, E. J. (1995). Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269, 529-531.
21. DiMaio, D. & Mattoon, D. (2001). Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20, 7866-7873.
22. England, J. J., Watson, R. E., Jr & Larson, K. A. (1973). Virus-like particles in an equine sarcoid cell line. Am J Vet Res 34, 1601-1603.
23. Faccini, A. M., Cairney, M., Ashrafi, G. H., Finbow, M. E., Campo M. S. & Pitts, J. D. (1996). The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol 70, 9041-9045.
24. Fatemi-Nainie, S., Anderson, L. W. & Cheevers, W. P. (1982). Identification of a transforming retrovirus from cultured equine dermal fibrosarcoma. Virology 120, 490-494.
25. Fatemi-Nainie, S., Anderson, L. W. & Cheevers, W. P. (1984). Culture characteristics and tumorigenicity of the equine sarcoid-derived MC-1 cell line. Am J Vet Res 45, 1105-1108.
26. Gerber, H., Dubath, M.-L. & Lazary, L. (1988). Association between predisposition to equine sarcoid and MHC in multiple-case families. In Equine Infectious Diseases, Proceedings of the Fifth International Conference, pp 272-277. Edited by D. G. Powel. Kentucky: University Press.
27. Giannoudis, A. & Herrington, C. S. (2001). Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193, 295-302.
28. Goldschmidt, M. H. & Hendrick, M. J. (2002). Equine sarcoid. In Tumours in Domestic Animals, 4th edition, pp 88-89. Edited by D. J. Meuten. Iowa: Iowa State University Press.
29. Goodrich, L., Gerber, H., Marti, E. & Antczack, D. F. (1998). Equine sarcoids. Vet Clin N Am Equine Prac 14, 607-623.
30. Han, R., Breitburd, F., Marche, P. N. & Orth, G. (1992). Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature 356, 66-68.
31. IARC. (1995). Monographs on the evaluation of carcinogenic risk to humans. In Human Papillomaviruses. World Health Organization International Agency for Research on Cancer.
32. Jackson, C. (1936). The incidence and pathology of tumours of domesticated animals in South Africa. Onderstepoort J Vet Sci Anim Ind 6, 378-385.
33. James, V. S. (1968). A family tendency to equine sarcoid. SW Vet 21, 235-236.
34. Jarrett, W. F. H., Smith, K. T., O'Neil, B. W., Gaukrodger, J. M., Chandrachud, L. M., Grindlay, G. J., McGarvie, G. M. & Campo, M. S. (1991). Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184, 33-42.
35. Kemp-Symonds, J. G. (2000). The detection and sequencing of bovine papillomavirus type 1 and 2 DNA from Musca autumnalis (Diptera: Muscidae) face flies infesting sarcoid-affected horses. MSc thesis, Royal Veterinary College, London, UK.
36. Knottenbelt, D. C. & Walker, J. A. (1994). Treatment of the equine sarcoid. Equine Vet Educ 6, 72-75.
37. Lancaster, W. D. (1981). Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells. Virology 108, 251-255.
38. Lancaster, W. D., Theilen, G. H. & Olson, C. (1979). Hybridization of bovine papilloma virus type 1 and type 2 DNA to DNA from virus-induced hamster tumors and naturally occurring equine tumors. Intervirology 11, 227-233.
39. Lazary, S., Gerber, H., Glatt, P. A. & Straub, R. (1985). Equine leucocyte antigens in sarcoid-affected horses. Equine Vet J 17, 283-286.
40. Lory, S., von Tscharner, C., Marti, E., Bestetti, G., Grimm, S. & Waldvogel, A. (1993). In situ hybridisation of equine sarcoids with bovine papilloma virus. Vet Rec 132, 132-133.
41. Marchetti, B., Ashrafi, G. H., Tsirimonaki, E., O'Brien, P. M. & Campo, M. S. (2002). The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 21, 7808-7816.
42. Martens, A., De Moor, A., Demeulemeester, J. & Peelman, L. (2001a). Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA. Vet Surg 30, 460-467.
43. Martens, A., De Moor, A. & Ducatelle, R. (2001b). PCR detection of bovine papilloma virus DNA in superficial swabs and scrapings from equine sarcoids. Vet J 161, 280-286.
44. Marti, E., Lazary, S., Antczak, D. F. & Gerber, H. (1993). Report of the first international workshop on equine sarcoid. Equine Vet J 25, 397-407.
45. Meredith, D., Elser, A. H., Wolf, B., Soma, L. R., Donawick, W. J. & Lazary, S. (1986). Equine leukocyte antigens: relationships with sarcoid tumors and laminitis in two pure breeds. Immunogenetics 23, 221-225.
46. Mohammed, H. O., Rebhun, W. C. & Antczack, D. F. (1992). Factors associated with the risk of developing sarcoid tumours in horses. Equine Vet J 24, 165-168.
47. Nasir, L. & Reid, S. W. J. (1999). Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Res 61, 171-175.
48. Nasir, L., McFarlane, S. T., Torrontegui, B. O. & Reid, S. W. J. (1997). Screening for bovine papillomavirus in peripheral blood cells of donkeys with and without sarcoids. Res Vet Sci 63, 289-290.
49. Nasir, L., McFarlane, S. T. & Reid. (1999). Mutational status of the tumour suppressor gene (p53) in donkey sarcoid tumours. Vet J 157, 99-101.
50. Ned, R., Allen, S. & Vande Pol, S. (1997). Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6. J Virol 71, 4866-4870.
51. O'Brien, P. M. & Campo, M. S. (2002). Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res 88, 103-117.
52. Olson, C., Jr & Cook, R. H. (1951). Cutaneous sarcoma-like lesions of the horse caused by the agent of bovine papilloma. Proc Soc Exp Biol Med 77, 281-284.
53. Otten, N., Von Tscharner, C., Lazary, S., Antczak, D. F. & Gerber, H. (1993). DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing. Arch Virol 132, 121-131.
54. Pascoe, R. R. & Summers, P. M. (1981). Clinical survey of tumours and tumour-like lesions in horses in south east Queensland. Equine Vet J 13, 235-239.
55. Ragland, W. L. & Spencer, G. R. (1969). Attempts to relate bovine papilloma virus to the cause of equine sarcoid: equidae inoculated intradermally with bovine papilloma virus. Am J Vet Res 30, 743-752.
56. Ragland, W. L., Keown, G. H. & Gorham. (1966). An epizootic of equine sarcoid. Nature 210, 1399.
57. Ragland, W. H., Keown, G. H. & Spencer, G. R. (1970). Equine sarcoid. Equine Vet J 2, 2-11.
58. Rapp, L., Liu, Y., Hong, Y., Androphy, E. J. & Chen, J. J. (1999). The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor α-induced apoptosis. Oncogene 18, 607-615.
59. Reid, S. W. J. (1992). The equine sarcoid: molecular and epidemiological studies in Equus asinus. PhD thesis, University of Glasgow, Glasgow, UK.
60. Reid, S. W. J. & Mohammed, H. O. (1997). Longitudinal and cross-sectional studies to evaluate the risk of sarcoid associated with castration. Can J Vet Res 61, 89-93.
61. Reid, S. W. J., Smith, K. T. & Jarrett, W. H. F. (1994). Detection, cloning and characterisation of papillomaviral DNA present in sarcoid tumours of Equus asinus. Vet Rec 135, 430-432.
62. Robl, M. G. & Olson, C. (1968). Oncogenic action of bovine papilloma virus in hamsters. Cancer Res 28, 1596-1604.
63. Schapiro, F., Sparkowski, J., Adduci, A., Suprynowicz, F., Schlegel, R. & Grinstein, S. (2000). Golgi alkalinization by the papillomavirus E5 oncoprotein. J Cell Biol 148, 305-315.
64. Scheffner, M., Werness, B. A., Huibregtse J. M., Levine, A. J. & Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
65. Shope, R. E. (1933). Infectious papillomatosis of rabbits; with a note on the histopathology. J Exp Med 58, 607-624.
66. Siegsmund, M., Wayss, K. & Amtmann, E. (1991). Activation of latent papillomavirus genomes by chronic mechanical irritation. J Gen Virol 72, 2787-2789.
67. Sousa, R., Dostatni, N. & Yaniv, M. (1990). Control of papillomavirus gene expression. Biochim Biophys Acta 1032, 19-37.
68. Straight, S. W., Herman, B. & McCance, D. J. (1995). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 69, 3185-3192.
69. Sundberg, J. P., Burnstein, T., Page, E. H., Kirkham, W. W. & Robinson, F. R. (1977). Neoplasms of Equidae. J Am Vet Med Assoc 170, 150-152.
70. Syverton, T. J. (1952). The pathogenesis of the rabbit papilloma-to-carcinoma sequence. Ann N Y Acad Sci 54, 1126-1140.
71. Thomsett, L. R. (1979). Skin diseases of the horse. In Pract 1, 15-26.
72. Tong, X. & Howley, P. M. (1997). The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci U S A 94, 4412-4417.
73. Tong, X., Salgia, R., Li, J. L., Griffin, J. D. & Howley, P. M. (1997). The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J Biol Chem 272, 33373-33376.
74. Tong, X., Boll, W., Kirchhausen, T. & Howley, P. M. (1998). Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J Virol 72, 476-482.
75. Torrontegui, B. O. & Reid, S. J. (1994). Clinical and pathological epidemiology of the equine sarcoid in a referral population. Equine Vet Educ 6, 85-88.
76. Trenfield, K., Spradbrow, P. B. & Vanselow, B. (1985). Sequences of papillomavirus DNA in equine sarcoids. Equine Vet J 17, 449-452.
77. Vambutas, A., DeVoti, J., Pinn, W., Steinberg, B. M. & Bonagura, V. R. (2001). Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol 101, 94-99.
78. Vande Pol, S. B., Brown, M. C. & Turner, C. E. (1998). Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16, 43-52.
79. Venuti, A. & Campo, M. S. (2002). The E5 protein of Papillomaviruses. In Progress in Medical Virology: Papillomaviruses, pp. 141-162. Edited by D. J. McCance. Iowa: Iowa State Press.
80. Voss, J. L. (1969). Transmission of equine sarcoid. Am J Vet Res 30, 183-191.
81. Wank, R. & Thomssen, C. (1991). High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352, 723-725.
82. Watson, R. E., Jr & Larson, K. A. (1974). Detection of tumor-specific antigens in an equine sarcoid cell line. Infect Immun 9, 714-718.
83. Zimmermann, H., Koh, C. H., Degenkolbe, R., O'Connor, M. J., Muller, A., Steger, G., Chen, J. J., Lui, Y., Androphy, E. & Bernard, H. U. (2000). Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J Gen Virol 81, 2617-2623.